The latest trading session saw CRISPR Therapeutics AG (CRSP) ending at $56.63, denoting a +1.22% adjustment from its last day's close. The stock exceeded the S&P 500, which registered a gain of 0.16% for the day. Elsewhere, the Dow saw an upswing of 0.04%, while the tech-heavy Nasdaq appreciated by 0.49%. Heading into today, shares of the company had gained 2.02% over the past month, lagging the Medical sector's gain of 2.32% and the S&P 500's gain of 3.22% in that time. The investment community will be pay ...